Dr. Seiji Bruce Shibata, MD, PhD

Dr. Shibata practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Shibata's NPI, 1750674370, was assigned on May 17, 2011. Dr. Shibata graduated from Other in 2007. Dr. Shibata holds California license A168954.

Dr. Shibata's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Shibata's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Shibata is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Shibata to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shibata practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Shibata's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Shibata is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Shibata's licenses on file in 2 states: California and Iowa.

Dmand AI lists acute sinusitis, chronic ear infection, ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear, tinnitus and vertigo among the conditions Dr. Shibata treats.

CMS data shows 1,183 Medicare services from Dr. Shibata across 7 procedure codes in 2024, for 454 Medicare patients. Medicare paid $59,784 for them.

CMS counts 454 Medicare patients who saw Dr. Shibata in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shibata's median patient age at 66, with 54% women.

In 2024, Dr. Shibata wrote 123 Medicare Part D claims for 70 patients. 88% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $3,045 in total drug cost. In 2023, CMS named 50 claims across 3 drugs.

Dr. Shibata accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shibata as offering telehealth.

Dmand AI links 11 papers to Dr. Shibata, published from 2011 to 2025. 2011 was the busiest year, with 2. The most frequent topics are Genetic Therapy, Genetic Vectors and Transgenes. Dr. Shibata's most frequent co-authors are Sarah R. Cortez, MD, Miles Jonathan Klimara, MD and Richard J. Smith, MD.

CMS Open Payments shows 5 general payments to Dr. Shibata from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. iotaMotion, Inc. paid the most, $271.

Dr. Shibata graduated from Other in 2007.

Dr. Shibata is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.